OCT Holdings Announces Rebrand to Octavian Therapeutics, Appointment of New Chair and Fundraising Launch

LONDON, Feb. 11, 2025 /PRNewswire/ -- Octavian Therapeutics ("Octavian" or "the Company"), a leading clinical-stage innovator in neuropathic pain treatment, today announces a transformative rebrand, the appointment of a new Non-Executive Chair, and a strategic fundraising initiative to...